Drug companies asked to deliver on a low-cost meningitis vaccine

Publisher： Elsevier

ISSN： 1473-3099

Source： The Lancet Infectious Diseases, Vol.2, Iss.11, 2002-11, pp. : 650-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benefits of Diuretic-Based Low-Cost Antihypertensive Therapy

By Giovanni de Simone Oreste de Divitiis

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 2, 2005-01 ,pp. : 73-78

Adis International

Access to resources Recommend Favorite

A Low-Cost, Low-Maintenance Approach: The Pasadena PasRide Pilot

By Kerschner Helen

Generations, Vol. 27, Iss. 2, 2003-07 ,pp. : 63-67

American Society on Aging

Access to resources Recommend Favorite

Imaging in drug development: will it deliver on the promise of personalised medicine?

By DZIK-JURASZ A

British Journal of Radiology, Vol. 83, Iss. 990, 2010-06 ,pp. : 453-455

British Institute of Radiology

Access to resources Recommend Favorite

A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting

By Aharonovich E. Hatzenbuehler M. Johnston B. O'Leary A. Morgenstern J. Wainberg M. Yao P. Helzer J. Hasin D.

AIDS Care, Vol. 18, Iss. 6, 2006-08 ,pp. : 561-568

Routledge Ltd

Access to resources Recommend Favorite

Low-Cost Intradermal Rabies Vaccination Is Indeed Very Promising

By Soentjens P. Aerssens A. Van Gucht S. Ravinetto R. Van Gompel A.

Clinical Infectious Diseases, Vol. 56, Iss. 10, 2013-05 ,pp. : 1509-1510

Oxford University Press

Access to resources Recommend Favorite